
New Targets Emerge for Aggressive Small Cell Lung Cancer
Published: | Updated:
Researchers explore innovative macrocyclic peptides to target small cell lung cancer, revealing promising therapeutic strategies for this aggressive disease.
Matthew Oser, MD, is an associate professor of medicine at Dana-Farber Cancer Institute and Harvard Medical School.

Researchers explore innovative macrocyclic peptides to target small cell lung cancer, revealing promising therapeutic strategies for this aggressive disease.

Published: September 16th 2025 | Updated: October 24th 2025